ALA 3.45% 15.0¢ arovella therapeutics limited

Hi Guys , was busy yesterday , thanks for your opinions . W.H.O....

  1. 539 Posts.
    lightbulb Created with Sketch. 106
    Hi Guys , was busy yesterday , thanks for your opinions .

    W.H.O. states in the report that artemisinin is the mainstay for malaria treatment and the efficacy
    needs to be protected since there are no new drugs expected within the next few years.
    W.H.O. reasoning sounds a bit strange , for phasing out oAMT's , and that is " the seven day treatment
    of oAMT 's are mostly not completed and resulting in the elimination of the weaker strains of the
    bacteria causing malaria and leaving the stronger strains . " therefore 7 day treatments will be phased out."
    "the continued use of oAMT's is considered to be the major contributing factor to the development of resistance to artimisinin derivatives ". WHO recommends a 3 day treatment.

    Kippax you spoke of your concerns to the company in 2012 but the decision to phase out oAMT's wasn't
    made until December 2013 and agreed upon by all the member countries . Also responses by the Suda should not be relied on ,imo.( since their is an obvious conflict of interest)
    Livas 1 , I appreciate your point of view and since I'm no expert , will consider your reasoning as valid ,
    however the market for Suda is now a subset of the available malaria treatment market . ( could you elaborate on the size of Suda's malaria market and do you think its still commercial )

    Look at the chart since the announcement in Dec 13 by WHO to phase out oAmt's , prior dec 13 chart was
    rising , since then the sp has been in a downtrend , Also it has been reported that an institutional investor
    has been selling out when Suda's is on the verge of Success. Too many negatives at the moment and the
    risk of success has risen.
    On the 6th june 14 report, a Suda announcement claims (Artmist) complete (100%)parasite removal
    within 30 hrs , a claim that has magically appeared ,(has never been claimed in any previous anns) ,which happens to fit WHO timeframe for treatment.
    Just guessing here but ,
    IMO , Suda will make two announcements ( as they have indicated )
    1. ARTMIST will not satisfy market expectations
    2. another product pending release (possibly migraine product) hoping to drown out the artimist disappointment .

    Goodluck to you all .
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
0.005(3.45%)
Mkt cap ! $138.7M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $301.1K 2.087M

Buyers (Bids)

No. Vol. Price($)
3 79105 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 357820 9
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
14.5¢
  Change
0.005 ( 2.84 %)
Open High Low Volume
14.5¢ 15.0¢ 14.0¢ 441083
Last updated 15.34pm 29/03/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.